NCT06866054 Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery
| NCT ID | NCT06866054 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kahramanmaras Sutcu Imam University |
| Condition | Shoulder Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-10 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-04-10 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postoperative pain is a significant problem in patients undergoing arthroscopic shoulder surgery. This situation disrupts the patient's comfort and affects the functional outcome after surgery by preventing early rehabilitation. Various methods are used for postoperative pain control. Intravenous opioid agents are one of the most commonly used analgesic techniques. However, opioids can cause undesirable side effects such as respiratory depression, sedation, constipation, allergic reactions, nausea, and vomiting. Therefore, alternative techniques are needed to reduce opioid use. Serratus posterior superior interfascial plane block (SPSIPB) is a novel interfascial plane block described by Tulgar et al in 2023. It is based on injection into the serratus posterior superior muscle at the level of the 2nd or 3rd rib. This block provides analgesia in cases such as interscapular pain, chronic myofascial pain syndromes, scapulocostal syndrome, and shoulder pain. It has been reported that SPSIPB provides effective shoulder analgesia.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) classification I-II * Scheduled for arthroscopic shoulder surgery under general anesthesia Exclusion Criteria: * history of bleeding diathesis, * receiving anticoagulant treatment, * known local anesthetics and opioid allergy, * infection of the skin at the site of the needle puncture, * patients who do not accept the procedure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06866054 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06866054 currently recruiting?
Yes, NCT06866054 is actively recruiting participants. Contact the research team at borabilal@gmail.com for enrollment information.
Where is the NCT06866054 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Kahramanmaraş, Turkey (Türkiye).
Who is sponsoring the NCT06866054 clinical trial?
NCT06866054 is sponsored by Kahramanmaras Sutcu Imam University. The trial plans to enroll 50 participants.